SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-011163
Filing Date
2020-02-20
Accepted
2020-02-20 17:02:49
Documents
1
Period of Report
2020-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 18837
  Complete submission text file 0001209191-20-011163.txt   20219
Mailing Address 2400 BAYSHORE PARKWAY SUITE 200 MOUNTAIN VIEW CA 94043
Business Address
CHAI CHRISTOPHER Y (Reporting) CIK: 0001413823 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38653 | Film No.: 20636139

Mailing Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Issuer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations